Peter J. Morrison

1.3k total citations
9 papers, 722 citations indexed

About

Peter J. Morrison is a scholar working on Immunology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Peter J. Morrison has authored 9 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Pathology and Forensic Medicine and 3 papers in Dermatology. Recurrent topics in Peter J. Morrison's work include Psoriasis: Treatment and Pathogenesis (4 papers), IL-33, ST2, and ILC Pathways (4 papers) and Dermatology and Skin Diseases (3 papers). Peter J. Morrison is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), IL-33, ST2, and ILC Pathways (4 papers) and Dermatology and Skin Diseases (3 papers). Peter J. Morrison collaborates with scholars based in Germany, United Kingdom and United States. Peter J. Morrison's co-authors include Brigitta Stockinger, Helena Ahlfors, Marika C. Kullberg, Christoph Wilhelm, Helena Helmby, Mark A. Wilson, Jan‐Eric Turner, Jean‐Christophe Renauld, Ulf Panzer and Sarah J. Ballantyne and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and American Journal Of Pathology.

In The Last Decade

Peter J. Morrison

9 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter J. Morrison Germany	8	553	257	100	88	60	9	722
Caroline Peine Germany	8	588 1.1×	149 0.6×	112 1.1×	83 0.9×	26 0.4×	11	743
Marie Cherrier France	10	1.1k 2.1×	415 1.6×	198 2.0×	61 0.7×	53 0.9×	14	1.3k
Rana Herro United States	16	267 0.5×	96 0.4×	126 1.3×	71 0.8×	43 0.7×	22	600
Mei‐Lun Wang United States	17	479 0.9×	821 3.2×	194 1.9×	83 0.9×	26 0.4×	23	1.2k
Anaïs Duval Switzerland	5	633 1.1×	282 1.1×	89 0.9×	203 2.3×	54 0.9×	5	775
Enayat Nikoopour Canada	15	341 0.6×	119 0.5×	130 1.3×	35 0.4×	31 0.5×	22	659
Sarah Lesjean‐Pottier France	8	1.4k 2.6×	565 2.2×	191 1.9×	51 0.6×	41 0.7×	8	1.6k
Koushi Ieki Japan	15	468 0.8×	84 0.3×	113 1.1×	245 2.8×	40 0.7×	19	741
Melanie Flach Germany	6	1.4k 2.4×	848 3.3×	95 0.9×	64 0.7×	24 0.4×	7	1.5k
Miho Odaka Japan	14	387 0.7×	72 0.3×	103 1.0×	209 2.4×	31 0.5×	18	639

Countries citing papers authored by Peter J. Morrison

Since Specialization

Citations

This map shows the geographic impact of Peter J. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Morrison more than expected).

Fields of papers citing papers by Peter J. Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Morrison. The network helps show where Peter J. Morrison may publish in the future.

Co-authorship network of co-authors of Peter J. Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Morrison. A scholar is included among the top collaborators of Peter J. Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Morrison. Peter J. Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Morrison, Peter J., et al.. (2022). Oral Dimethyl Fumarate Targets HCA2-Expressing Skin Cells in the Imiquimod Mouse Model. Journal of Investigative Dermatology. 142(9). 2547–2550.e5. 2 indexed citations

Geisen, Ulf, Melike Sümbül, Florian Tran, et al.. (2021). Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies. RMD Open. 7(3). e002008–e002008. 12 indexed citations

Morrison, Peter J., et al.. (2021). Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement*. British Journal of Dermatology. 185(3). 605–615. 11 indexed citations

Mrowietz, Ulrich, et al.. (2017). The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects. Trends in Pharmacological Sciences. 39(1). 1–12. 76 indexed citations

Morrison, Peter J., Sarah J. Ballantyne, Sandy MacDonald, et al.. (2015). Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus. American Journal Of Pathology. 185(12). 3290–3303. 18 indexed citations

Ahlfors, Helena, Peter J. Morrison, João H. Duarte, et al.. (2014). IL-22 Fate Reporter Reveals Origin and Control of IL-22 Production in Homeostasis and Infection. The Journal of Immunology. 193(9). 4602–4613. 98 indexed citations

Turner, Jan‐Eric, Peter J. Morrison, Christoph Wilhelm, et al.. (2013). IL-9–mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. The Journal of Experimental Medicine. 210(13). 2951–2965. 339 indexed citations

Morrison, Peter J., David Bending, Lynette A. Fouser, et al.. (2013). Th17-cell plasticity in Helicobacter hepaticus–induced intestinal inflammation. Mucosal Immunology. 6(6). 1143–1156. 85 indexed citations

Morrison, Peter J., Sarah J. Ballantyne, & Marika C. Kullberg. (2011). Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology. 133(4). 397–408. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact